跳至主要内容
临床试验/EUCTR2010-023941-31-DE
EUCTR2010-023941-31-DE进行中(未招募)1 期

Effects of EGCG (Epigallocatechin Gallate) in Chorea Huntington - ETO

Charité Universitätsmedizin Berlin0 个研究点目标入组 54 人开始时间: 2011年3月17日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Chorea Huntington (CAG repeats > 39)
  • UHDRS TFC > 5
  • = 18 years
  • Stable medication 4 weeks before baseline
  • no further participation in other interventional trials during and 3 months before/after ETON trial
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 54

排除标准

  • any clinically significant deviation of lab values, vital signs or ECG at baseline
  • long-term medication with hepatotoxic substances
  • instable medical disorder
  • cognitive deficits (MMSE-Score <23)
  • BDI depression score > 9 or clinical diagnosis of depression
  • other primary neurological disorder
  • current alcohol or drug abuse
  • known liver oder kidney disease
  • known anemia
  • pregnancy/lactation

研究者

相似试验